London: Research on the ChAdOx1 nCoV-19, also known as the Oxford-AstraZeneca vaccine, indicates that a long interval between first and second doses does not compromise the immune response after a late second dose, and a third dose of the vaccine continues to boost antibodies against SARS-CoV-2. The results were released in a preprint today. COVID-19 […]
Delayed second dose and third doses of the Oxford-AstraZeneca vaccine lead to heightened immune response to SARS-CoV-2
- Post author:admin
- Post published:June 28, 2021
- Post category:Uncategorized
Tags: Education News